Lawrence Yannuzzi is an American physician, ophthalmologist, and vitreo-retinal surgeon who is noted as an internationally recognized retinal specialist. [1]
Yannuzzi graduated from Harvard College. He graduated from the Boston University School of Medicine where he received an M.D. degree in 1964. He did a residency in ophthalmology at the Manhattan Eye, Ear and Throat Hospital from 1965 to 1968. He was board certified in ophthalmology in 1971. [2]
He is married and has two sons and a daughter, who is a psychiatrist. [3]
He is a professor of clinical ophthalmology at Columbia University College of Physicians and Surgeons, vice–chairman and director of The Retinal Research Center of the Manhattan Eye, Ear & Throat Hospital, and founder and president of The Macula Foundation. [4]
Yannuzzi has published more than 550 scientific papers and 12 textbooks, with particular concentration in diseases of the macula such as diabetic retinopathy and age-related macular degeneration. [5]
He is on the board of directors for Lighthouse International, a non-profit organization that does work in Vision Rehabilitation services, education, research, prevention and advocacy. [1]
Yannuzzi is a pioneer in angiography. [6] He and his colleagues are credited as describing and coining the term "idiopathic polypoidal choroidal vasculopathy", a particular type of hemorrhagic maculopathy. [7]
Professor of Clinical Ophthalmology, NYU Professor of Clinical Ophthalmology, Columbia University[ citation needed ]
Ophthalmology is a clinical and surgical specialty within medicine that deals with the diagnosis and treatment of eye disorders. A former term is oculism.
Manhattan Eye, Ear and Throat Hospital (MEETH) is a specialty hospital in New York City that was founded in 1869 and is currently located on the Upper East Side of Manhattan at 210 East 64th Street. After 131 years as an independent entity, in 2000 MEETH affiliated with Lenox Hill Hospital, a 652-bed acute care hospital, established in New York City in 1857 and located at 77th Street in Manhattan. MEETH is recognized in medical circles for its long history of contributions in developing the fields of ophthalmology, otolaryngology and plastic surgery. MEETH provides thousands of patients a year with treatment in its ambulatory surgery facilities.
Charles Louis Schepens was a Belgian and American ophthalmologist, regarded by many in the profession as "the father of modern retinal surgery", and member of the French Resistance.
Cornelius Rea Agnew was an American surgeon.
Ian Jeffrey Constable is an Australian ophthalmologist and the founder and director of the Lions Eye Institute in Perth, Western Australia. He was the Foundation Lions Professor of Ophthalmology at the University of Western Australia, and the Foundation Director of UWA's Centre for Ophthalmology and Visual Science. He is now Patron of the Lions Eye Institute.
New York Eye and Ear Infirmary of Mount Sinai (NYEE) is located at East 14th Street and Second Avenue in lower Manhattan, New York City. Founded on August 14, 1820, NYEE is America's first specialty hospital and one of the most prominent in the fields of ophthalmology and otolaryngology in the world, providing primary inpatient and outpatient care in those specialties. Previously affiliated with New York Medical College, as of 2013 it is affiliated with the Icahn School of Medicine at Mount Sinai as a part of the membership in the Mount Sinai Health System.
The Illinois Eye & Ear Infirmary (IEEI) is a center of ophthalmology and otolaryngology research and clinical practice.
David Anthony Newsome M.D. FARVO was a scientist, ophthalmologist, inventor, and author. He studied the treatment of age-related macular degeneration and proposed the usefulness of zinc supplements to slow the rate of vision loss from age-related macular degeneration.
Paul T. Finger, MD, FACS, is an ophthalmologist in New York, New York, specializing in ocular oncology. Finger is a Clinical Professor of Ophthalmology at the New York University School of Medicine in New York City, New York. He is also the director of The New York Eye Cancer Center and Ocular Tumor Services at The New York Eye and Ear Infirmary of Mt. Sinai. He consults for Northwell Health Complex of affiliated Hospitals including Manhattan Eye, Ear and Throat Hospital and NYU School of Medicine. He is Chair of the Ophthalmic Oncology Task Force for the American Joint Committee on Cancer (AJCC), wrote the eye cancer staging systems section for the Union International for Cancer Control (UICC). As Chair, he brought together an OOTF to develop consensus eye plaque radiation guidelines for The American Brachytherapy Society - American Association of Physicists in Medicine. Dr. Finger was the first the only ophthalmologist asked to serve on the 2012 American Association of Physicists in Medicine’s Task Group-129 that produced both dosimetry and quality assurance standards for plaque brachytherapy. As of 2021, Dr. Finger has authored over 335 peer-review scientific articles, 2 books, 54 book chapters and 2 web sites.
Ron P. Gallemore is a registered ophthalmologist with the American Academy of Ophthalmology involved in research and treatment of diseases of the macula and retina.
Arnall Patz was an American medical doctor and research professor at Johns Hopkins University. In the early 1950s, Patz discovered that oxygen therapy was the cause of an epidemic of blindness among some 10,000 premature babies. Following his discovery, there was a sixty percent reduction in childhood blindness in the United States. He also conducted pioneering research in the 1960s into the use of lasers in the treatment of retinal disorders. He received the Lasker Award in 1956 for his research into the causes and prevention of blindness and the Presidential Medal of Freedom in 2004 for his lifetime of work in the field of ophthalmology.
Bascom Palmer Eye Institute is the University of Miami School of Medicine's ophthalmic care, research, and education center. The institute is based in the Health District of Miami, Florida, and has been ranked consistently as the best eye hospital and vision research center in the nation.
Julia A. Haller is an American ophthalmologist who is a Professor and Chair of the Department of Ophthalmology at Sidney Kimmel Medical College at Thomas Jefferson University. She also holds the William Tasman, M.D. Endowed Chair at Wills Eye Hospital in Philadelphia, where she is Ophthalmologist-in-Chief.
Bruce Mitchel Zagelbaum is an American ophthalmologist specializing in cornea and external disease, laser vision correction, eye trauma, and sports ophthalmology. He authored the textbook Sports Ophthalmology, and was the principal investigator in eye injury studies involving players in Major League Baseball and in the National Basketball Association. He is an associate clinical professor of ophthalmology at Hofstra North Shore - LIJ School of Medicine and North Shore University Hospital where he is an attending physician.
Joan Whitten Miller is a Canadian-American ophthalmologist and scientist who has made notable contributions to the treatment and understanding of eye disorders. She is credited for developing photodynamic therapy (PDT) with verteporfin (Visudyne), the first pharmacologic therapy for retinal disease. She also co-discovered the role of vascular endothelial growth factor (VEGF) in eye disease and demonstrated the therapeutic potential of VEGF inhibitors, forming the scientific basis of anti-VEGF therapy for age-related macular degeneration (AMD), diabetic retinopathy, and related conditions.
The Legacy Devers Eye Institute in Portland, Oregon, is one of the few private, non-profit centers for ophthalmological care, research, and training in the United States. The institute is affiliated with Legacy Health, a network of seven hospitals in Portland and Southwest Washington. Legacy Devers includes the Thelma and Gilbert Schnitzer Comprehensive Glaucoma Center.
Emily Ying Chew is an American ophthalmologist and an expert on the human retina with a strong clinical and research interest in diabetic eye disease and age-related eye diseases. She currently works for the National Eye Institute (NEI) at the National Institutes of Health (NIH) in Bethesda, Maryland, where she serves as deputy director of the Division of Epidemiology and Clinical Applications (DECA) and the Institute's deputy clinical director. She designs and implements Phase 1, 2 and 3 clinical trials at the NIH Clinical Center. Chew is board certified in ophthalmology.
Neil M. Bressler is an American ophthalmologist. He is the James P. Gills Professor of Ophthalmology and chief of the Retina Division at the Wilmer Eye Institute at Johns Hopkins School of Medicine and editor-in-chief of JAMA Ophthalmology.
Richard Frederick Spaide is an American ophthalmologist and retinal specialist known for his work in retinal diseases and advancements in ocular imaging techniques.
Henry Drury Noyes was an American physician, surgeon, optometrist, and former president of the American Ophthalmological Society.